Literature DB >> 16400059

Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease.

Erica P A Rutten1, Marielle P K J Engelen, Emiel F M Wouters, Annemie M W J Schols, Nicolaas E P Deutz.   

Abstract

BACKGROUND: Because low plasma glutamate and glutamine concentrations are often seen in chronic obstructive pulmonary disease (COPD), glutamine or glutamate supplementation may be a good option for preventing further metabolic disturbances in COPD patients. However, the metabolic effects of glutamate supplementation have never been compared with those of glutamine supplementation.
OBJECTIVE: We compared the metabolic effects of repeated ingestion of glutamine and glutamate in COPD patients and in age-matched healthy control subjects.
DESIGN: On 3 d separated by intervals of > or = 2 d, a protocol of primed constant and continuous infusion of [2H5]phenylalanine and [2H2]tyrosine was performed for 3 h in 8 stable male COPD patients and 8 healthy control subjects. After a 90-min tracer infusion, all subjects ingested a glutamine or glutamate drink or the same amount of water every 20 min for 80 min. Blood samples were taken at the end of the postabsorptive and ingestion periods to test for effects on plasma amino acid and substrate concentrations and whole-body protein turnover.
RESULTS: Glutamate but not glutamine ingestion resulted in higher plasma ornithine concentrations than did water ingestion (P < 0.01). The change in plasma arginine, citrulline, and urea concentrations was significantly (P < 0.01) higher after glutamine ingestion than after water or glutamate ingestion. Whole-body protein turnover decreased overall, independent of the drink consumed.
CONCLUSIONS: Repeated ingestion of glutamine and glutamate resulted in different effects on the plasma amino acid concentration. In both groups, ingestion of glutamine but not of glutamate increased the plasma concentrations of citrulline and arginine, substrates produced in the intestine and the liver.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400059     DOI: 10.1093/ajcn/83.1.115

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  9 in total

1.  Is glutamine still an important precursor of citrulline?

Authors:  G C Ligthart-Melis; N E P Deutz
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-10       Impact factor: 4.310

2.  Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.

Authors:  A M Beaufrère; N Neveux; P Patureau Mirand; C Buffière; G Marceau; V Sapin; L Cynober; D Meydinal-Denis
Journal:  J Nutr Health Aging       Date:  2014-11       Impact factor: 4.075

3.  Glutamine: precursor or nitrogen donor for citrulline synthesis?

Authors:  Juan C Marini; Inka Cajo Didelija; Leticia Castillo; Brendan Lee
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-04-20       Impact factor: 4.310

4.  Arginine and ornithine are the main precursors for citrulline synthesis in mice.

Authors:  Juan C Marini
Journal:  J Nutr       Date:  2012-02-08       Impact factor: 4.798

Review 5.  Glutamate: A Safe Nutrient, Not Just a Simple Additive.

Authors:  Cécile Loï; Luc Cynober
Journal:  Ann Nutr Metab       Date:  2022-02-16       Impact factor: 5.923

6.  Citrulline Generation Test: What Does It Measure?

Authors:  Mahmoud A Mohammad; Inka C Didelija; Barbara Stoll; Juan C Marini
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-10-24       Impact factor: 4.016

7.  Metabolomic profiles of current cigarette smokers.

Authors:  Ping-Ching Hsu; Renny S Lan; Theodore M Brasky; Catalin Marian; Amrita K Cheema; Habtom W Ressom; Christopher A Loffredo; Wallace B Pickworth; Peter G Shields
Journal:  Mol Carcinog       Date:  2016-08-22       Impact factor: 4.784

Review 8.  Glutamine metabolism in advanced age.

Authors:  Dominique Meynial-Denis
Journal:  Nutr Rev       Date:  2016-03-02       Impact factor: 7.110

Review 9.  Exogenous Glutamine in Respiratory Diseases: Myth or Reality?

Authors:  Gisele P Oliveira; Marcelo Gama de Abreu; Paolo Pelosi; Patricia R M Rocco
Journal:  Nutrients       Date:  2016-02-04       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.